The FDA approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tou...
Regulators, clinicians, and health care algorithm developers need to take additi...
A new online marketplace called aRukon is set to launch globally this year to he...
UnitedHealth Group quietly acquired dozens of outpatient facilities in 2023, acc...
Across the country, there’s widespread disagreement — among doctors, lawmakers, ...
While the NIH has been working toward inclusion of underrepresented groups in th...
Medicare will make advance payments to physician groups, hospitals, and other fa...
Eli Lilly will be unveiling a new campaign during this weekend’s Oscar awards ev...
Upcoming regulatory events for pipeline AAV gene therapies, with a focus on neur...
In letters to the editor, high-risk people express concern about the CDC’s new C...
Participants cannot remain blind to their treatment arm due to the properties of...
While some biotechs are attempting to develop disease-modifying therapies for am...
While Lilly’s Alzheimer’s drug was previously expected in Q1 2024, an FDA-mandat...
The FDA has already granted accelerated approvals to several third-line treatmen...
The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease...
Amylyx’s stocks plummeted by more than 85% after announcing it is considering sc...
